In healthcare research the finding is only as trustworthy as the certainty that a real, practising clinician gave the answer. Self-administered online panels — fast and valuable for many studies — struggle to provide that certainty for small, high-value clinical audiences, where the incentive to fake a credential runs highest. This is the data-quality case for a live, clinically-aware telephone interview: what it verifies, what it captures, and what one fake clinician costs.
CatalystMR Research Team. (2026). CATI for Healthcare Research: Verifiable, High-Fidelity HCP Data. CatalystMR Methodology Papers. https://www.catalystmr.com/insights/methodology-papers/cati-for-healthcare-research/
@techreport{catalystmr_cati_for_healthcare_research,
author={{CatalystMR Research Team}},
title={CATI for Healthcare Research: Verifiable, High-Fidelity HCP Data},
institution={CatalystMR}, year={2026}, type={Methodology Paper},
url={https://www.catalystmr.com/insights/methodology-papers/cati-for-healthcare-research/}
}TY - RPRT AU - CatalystMR Research Team TI - CATI for Healthcare Research: Verifiable, High-Fidelity HCP Data PB - CatalystMR PY - 2026 UR - https://www.catalystmr.com/insights/methodology-papers/cati-for-healthcare-research/ ER -
Healthcare market research carries unusually high stakes: its findings shape launches, formularies, and clinical messaging. Yet it runs on some of the hardest respondents to verify — clinicians whose expertise no checkbox can confirm, drawn from populations small enough that a single fraudulent complete can move a result. Across online research, industry analyses estimate a substantial share of data is discarded over quality and fraud concerns, and peer-reviewed work shows the threat falls hardest on small target populations — exactly the rare specialties healthcare studies depend on.
This paper makes the data-quality case for computer-assisted telephone interviewing (CATI) in healthcare — not as the only mode, but as the one that delivers verifiable, high-fidelity data where it matters most. It maps where HCP panel quality breaks down; shows what a live clinical interview verifies that a form cannot; names the quality a conversation captures; states honestly where self-administered modes still win; and traces what one fake clinician costs downstream. It is the healthcare companion to the B2B case of No. 145 and the mode decision of No. 135.
Most quality frameworks treat fraud as noise to be filtered. In healthcare research it is closer to a single point of failure. The findings steer billion-dollar launches and clinical decisions, yet they rest on respondents whose competence a form cannot confirm and on specialty cells small enough that a few bad completes do not blur the result — they become it. The first question is not "what did clinicians say?" but "were they clinicians at all?"
These figures describe online research broadly; healthcare concentrates the risk. Rare specialties carry the highest incentive to fake a credential and the smallest base to absorb the damage, and "imposter participants" are a documented, growing threat to online data integrity.2 None of this makes online panel wrong — for broad, reachable HCP audiences it is fast and valuable. It means that where the audience is small, specialised, and decision-critical, verification is the product, and a method that cannot verify is a liability dressed as a dataset.
Standard quality controls — deduplication, attention checks, timing — catch generic bad actors. They were not built for the specific ways healthcare data goes wrong, where the threat is not a careless respondent but a convincing impostor in a population too small to hide the damage. Four failure points are distinctly healthcare's.
A rare specialty pairs the highest incentive to fake a credential with the smallest base to absorb it. Fraud concentrates exactly where validity is most fragile.1
Clinical expertise is not a profile field. A screener captures a claimed specialty; it cannot tell whether the respondent can reason, prescribe, or sequence treatment like one who practises.
Opt-in panels and open links attract serial and imposter participants chasing incentives — a documented and increasing threat to online data integrity.2
Generative tools now produce plausible-sounding clinical verbatims that survive a casual read while reflecting no real practice — hollowing out the very answers meant to add depth.
Each failure shares a root: the screener and the cleaning pass both act on what a respondent claims, not on whether they are who they say. In a small clinical cell, by the time a post-field check flags a problem, the contaminated completes may already be the majority. The durable fix moves verification upstream, to the moment of contact.
A live interview moves the integrity check from the dataset to the doorway. Within the first minutes of a CATI call, two assurances a screen-and-submit survey can never give are already in hand: the interviewer confirms they are speaking to the named, intended clinician, and a clinically-aware interviewer hears whether that clinician actually practises. Credentials open the door; the conversation confirms the room.
Registry matching — NPI, license, association records — verifies that a credential exists; it is the first gate, and the subject of No. 132. A live interview adds the gate a registry can't: competence in conversation. An interviewer briefed on the therapeutic area can tell, quickly, whether answers carry the texture of real practice — the right drug names, the plausible sequencing, the caveats a practitioner would raise unprompted.
The risk is not hypothetical. In one widely-cited account, a study's "hemophilia nurses" treated hand soap as a treatment — where a real nurse would name factor-replacement therapy. They were not nurses at all, and only a clinical read caught it before it reached a launch decision.
Ask: "At what point does someone who actually understands this specialty hear the respondent?" If the answer is "never," competence was never verified.
Verification is the floor, not the ceiling. Once you know a real clinician is on the line, the conversation captures a fidelity a grid cannot — including benefits buyers rarely price in until they see the difference in the transcript.
You reach and speak with the named, verified clinician — not an anonymous profile, a shared login, or a proxy filling in for the incentive.
A clinically-aware interviewer hears within minutes whether the respondent practises. Fraud that clears a screener fails a conversation.
Captures how an HCP actually decides — sequencing, rationale, real-world workarounds — in their own words. Richer than a forced grid, and far harder to fake or AI-generate.
Interviewer pacing curbs the satisficing and straight-lining that long therapeutic-area batteries invite — so late-survey answers stay as careful as the first.
Verified call lists reach rare specialties without the open links and outsized incentives that invite imposters in the first place — prevention, not just detection.
A live interviewer is not a free upgrade, and CATI is not the answer to every healthcare study. There is one area where self-administration is genuinely better, and naming it is what makes the rest of this paper trustworthy: a method partner who tells you where their method loses can be believed on where it wins.
The defensible design is rarely all-or-nothing. Use CATI where verification, specialist reach, complexity, or reasoning drive value; use self-administration where candor, scale, or cost do — sometimes within one study, under a single master screener. The mode decision is the subject of No. 135; combining modes well is No. 141.
Match the mode to what the study most needs to protect: certainty and depth, or candor and scale. High-stakes specialist work usually needs the former.
The case for verification is clearest when you follow a single fraudulent complete downstream. In a small specialty cell it does not get diluted — it propagates, and each step magnifies the last until a real decision rests on data that was never real.
A non-clinician — or an AI — clears the screener in a small specialty cell and is paid as a qualified respondent.
In a base of dozens, that one complete shifts a therapeutic-area rating, awareness, or preference figure on its own.
Driver analysis, segmentation, or a forecast inherits the error; the wrong attribute or segment surfaces as the "insight."
A launch sequence, formulary pitch, or clinical message is shaped by data that was never real — at stakes measured in patients and dollars.
Healthcare research asks more of its data than almost any other field, and gives it less margin for error: small populations, high incentives to impersonate, and decisions too consequential to rest on respondents who were never verified. Self-administered online panels remain fast and valuable for broad, reachable audiences and for sensitive self-report, where the absence of an interviewer is an advantage. But where the audience is small, specialised, and decision-critical, a live, clinically-aware telephone interview does what a form cannot — it confirms the clinician is real, hears whether they truly practise, captures the reasoning a grid flattens, and keeps a single impostor from becoming the finding. The strongest programs blend the two, matching mode to what the study most needs to protect. Recognised conduct and service-quality frameworks let buyers ask for that rigour in consistent terms.3,4
CatalystMR is a global market-research panel and fieldwork partner specialising in hard-to-reach healthcare, B2B, and niche audiences. We field live CATI interviewing with clinically-briefed, monitored interviewers against verified HCP sample, adding a competence check no checkbox provides — and we advise honestly on when telephone, online panel, or a blend under one master screener best protects the result.
Borderline completes are replaced rather than silently deleted, so a study keeps both its quality and its planned base.
Compliance posture: aligned to the ESOMAR Code and Guidelines and the ISO 20252 framework; certified under the EU–U.S., UK, and Swiss Data Privacy Frameworks, with personal data siloed from response data.